Johanna I. Kiiski
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.
Journal: Clinical pharmacology and therapeutics
Published: November 29, 2025
Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multicentre Trial.
Journal: Basic & clinical pharmacology & toxicology
Published: November 18, 2024
A Phenotyping Tool for Seven Cytochrome P450 Enzymes and Two Transporters: Application to Examine the Effects of Clopidogrel and Gemfibrozil.
Journal: Clinical pharmacology and therapeutics
Published: November 14, 2024
Genetic and Functional Characterization of DPYD Exon 4 Deletion Common in the Finnish Population.
Journal: Basic & clinical pharmacology & toxicology
Published: October 10, 2024
Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing.
Journal: Clinical pharmacokinetics
Published: September 30, 2024
Does cytochrome 2D6 genotype affect the analgesic efficacy of codeine after ambulatory surgery? Prospective trial in 987 adults.
Journal: Acta anaesthesiologica Scandinavica
Published: May 22, 2024
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.
Journal: Human genomics
Published: November 02, 2023
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.
Journal: Clinical pharmacology and therapeutics
Published: August 04, 2023
Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2 , and CYP2C9 variants.
Journal: Pharmacogenetics and genomics
Published: July 25, 2023
CYP2C19 loss-of-function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel.
Journal: Clinical and translational science
Published: June 12, 2023
Posaconazole-ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment.
Journal: British journal of clinical pharmacology
Published: May 21, 2023
Last Updated: 09/26/2026